Global Urinary Incontinence Markets, 2018-2022 & 2023-2028: Companies Innovate Advertisements to Promote Urinary Incontinence Awareness as Disposables Dominate – ResearchAndMarkets.com

The “Global Urinary Incontinence Market (2023 Edition) – Analysis By Incontinence Type (Stress, Urge, Mixed, Others), Product Type, End-user, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report has been added to ResearchAndMarkets.com’s offering.

The Global Urinary Incontinence Market is expected to generate USD 21.1 billion by the end of 2028, up from USD 14,664.64 million in 2021. During the forecast period, 2023-2028, the Global Urinary Incontinence market is expected to expand at a CAGR of 8.12%.

The research is global in nature and covers a detailed analysis of the market in America (U.S., Canada, Rest of Americas), Europe (Germany, U.K, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), and the Middle East and Africa.

Additionally, the research report displays data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and strategic recommendations. The research study also looks at the market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

Urinary Incontinence is a global health issue that affects around 200 million people globally. The disorder may occur at any age due to several factors however it’s largely associated with the elderly population because of the high prevalence of UI in adults over age 65, who are the key end-user demographic of Urinary incontinence products.

Moreover, Urinary Incontinence is twice as prominent in Women than in Men. This is due to the fact that women’s reproductive health events, such as pregnancy, delivery, and menopause, alter the bladder, urethra, and other pelvic floor muscles that support these organs. Additionally, Diabetes, Obesity, Chronic lung infections and cough, neurological conditions and prostate disorders are risk factors associated with Urinary incontinence which is consequentially backing the market growth.

Companies are choosing interactive and engaging advertisements to battle social stigmas associated with the disease because people who experience, urinary incontinence are often subjected to stigma and psychological distress. Urinary incontinence is a condition that many individuals find embarrassing or afraid to discuss, which can result in a restraint to the flourishing growth of the market. Among product types, disposables hold the maximum share in the market.

The global market for urinary incontinence disposables is expected to grow in the coming years, driven by several factors such as the increasing prevalence of urinary incontinence and the growing demand for convenient and discreet solutions. Adult diapers, pads, and liners are among the most common types of urinary incontinence disposables, providing patients with comfort, confidence, and the ability to maintain their normal activities and routines.

The report provides a detailed overview of the Global Urinary Incontinence Market, which will assist industry consultants, equipment manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders in aligning their market-centric strategies with current and expected future trends.

Report Highlights

  • Impact Analysis of Macro Economic Factors on the Urinary Incontinence Market
  • Impact of COVID-19 on Urinary Incontinence Market
  • Global Urinary Incontinence Market: Ecosystem Analysis
  • Urinary Incontinence Clinical Trials
  • Prevalence of Urinary Incontinence in diabetic and non-diabetic patients

Global Urinary Incontinence Market: Historic and Forecast (2018-2028)

Global Urinary Incontinence Market Segmentation: By Incontinence Type

  • Global Urinary Incontinence Market, By Incontinence Type Overview
  • Global Urinary Incontinence Market Size, By Stress Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Urge Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Mixed Incontinence, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Other Incontinence, By Value, 2018H-2028F (USD Million & CAGR)

Global Urinary Incontinence Market Segmentation: By Product Type

  • Global Urinary Incontinence Market, By Product Type Overview
  • Global Urinary Incontinence Market Size, By Devices, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Disposables, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Other Product Types, By Value, 2018H-2028F (USD Million & CAGR)

Global Urinary Incontinence Market Segmentation: By End-User

  • Global Urinary Incontinence Market, By End-User Overview
  • Global Urinary Incontinence Market Size, By Hospitals, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Specialty Clinics, By Value, 2018H-2028F (USD Million & CAGR)
  • Global Urinary Incontinence Market Size, By Homecare, By Value, 2018H-2028F (USD Million & CAGR)

Competitive Positioning

  • Companies’ Product Positioning
  • Market Position Matrix
  • Market Share Analysis of the Urinary Incontinence Market

Company Profiles

  • Boston Scientific
  • Becton Dickinson & Company
  • Coloplast
  • Caldera Cook Group Inc.
  • Cook Group Inc.
  • Convatec Group Plc
  • Medtronic Plc
  • Teleflex Incorporated
  • Asahi Kasei Corporation
  • Berry Global
  • Cardinal Health Incorporated

For more information about this report visit https://www.researchandmarkets.com/r/t0wn9p

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.